Caris Financial Statements From 2010 to 2025
| CAI Stock | USD 28.00 0.46 1.62% |
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
Check out the analysis of Caris Life Correlation against competitors. Caris Life Sciences, Company Shares Outstanding Analysis
Caris Life's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Caris Life Shares Outstanding | 283.56 M |
Most of Caris Life's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Caris Life Sciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Caris Life Sciences, has 283.56 M of shares currently outstending. This is 94.56% higher than that of the Trading Companies & Distributors sector and significantly higher than that of the Industrials industry. The shares outstanding for all United States stocks is 50.41% higher than that of the company.
Caris Life Sciences, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Caris Life's current stock value. Our valuation model uses many indicators to compare Caris Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Caris Life competition to find correlations between indicators driving Caris Life's intrinsic value. More Info.Caris Life Sciences, is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Caris Life's earnings, one of the primary drivers of an investment's value.About Caris Life Financial Statements
Investors use fundamental indicators, such as Caris Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California. Cai International operates under Rental Leasing Services classification in the United States and is traded on New York Stock Exchange. It employs 99 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Caris Life Correlation against competitors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences, is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.